74 related articles for article (PubMed ID: 27374259)
1. Switching enhancer methylation in metastatic melanoma.
Pfeifer GP
Pigment Cell Melanoma Res; 2016 Sep; 29(5):491-3. PubMed ID: 27374259
[No Abstract] [Full Text] [Related]
2. The DNA methylation landscape of human melanoma.
Jin SG; Xiong W; Wu X; Yang L; Pfeifer GP
Genomics; 2015 Dec; 106(6):322-30. PubMed ID: 26384656
[TBL] [Abstract][Full Text] [Related]
3. Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma.
Cheng PF; Shakhova O; Widmer DS; Eichhoff OM; Zingg D; Frommel SC; Belloni B; Raaijmakers MI; Goldinger SM; Santoro R; Hemmi S; Sommer L; Dummer R; Levesque MP
Genome Biol; 2015 Feb; 16(1):42. PubMed ID: 25885555
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of the MGMT promoter methylation status in metastatic melanoma patients receiving first-line temozolomide plus bevacizumab in the trial SAKK 50/07.
Schraml P; von Teichman A; Mihic-Probst D; Simcock M; Ochsenbein A; Dummer R; Michielin O; Seifert B; Schläppi M; Moch H; von Moos R
Oncol Rep; 2012 Aug; 28(2):654-8. PubMed ID: 22614944
[TBL] [Abstract][Full Text] [Related]
5. Promoter hypermethylation of the O(6)-methylguanine DNA methyltransferase gene and microsatellite instability in metastatic melanoma.
Kohonen-Corish MR; Cooper WA; Saab J; Thompson JF; Trent RJ; Millward MJ
J Invest Dermatol; 2006 Jan; 126(1):167-71. PubMed ID: 16417233
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation subgroups in melanoma are associated with proliferative and immunological processes.
Lauss M; Ringnér M; Karlsson A; Harbst K; Busch C; Geisler J; Lønning PE; Staaf J; Jönsson G
BMC Med Genomics; 2015 Nov; 8():73. PubMed ID: 26545983
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic inactivation of RASSF1a in uveal melanoma.
Maat W; van der Velden PA; Out-Luiting C; Plug M; Dirks-Mulder A; Jager MJ; Gruis NA
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):486-90. PubMed ID: 17251440
[TBL] [Abstract][Full Text] [Related]
8. Profiling epigenetic inactivation of tumor suppressor genes in tumors and plasma from cutaneous melanoma patients.
Hoon DS; Spugnardi M; Kuo C; Huang SK; Morton DL; Taback B
Oncogene; 2004 May; 23(22):4014-22. PubMed ID: 15064737
[TBL] [Abstract][Full Text] [Related]
9. Promoter Methylation of PTEN Is a Significant Prognostic Factor in Melanoma Survival.
Roh MR; Gupta S; Park KH; Chung KY; Lauss M; Flaherty KT; Jönsson G; Rha SY; Tsao H
J Invest Dermatol; 2016 May; 136(5):1002-1011. PubMed ID: 26854490
[TBL] [Abstract][Full Text] [Related]
10. DNA Methylation Levels of Melanoma Risk Genes Are Associated with Clinical Characteristics of Melanoma Patients.
de Araújo ÉS; Pramio DT; Kashiwabara AY; Pennacchi PC; Maria-Engler SS; Achatz MI; Campos AH; Duprat JP; Rosenberg C; Carraro DM; Krepischi AC
Biomed Res Int; 2015; 2015():376423. PubMed ID: 26106605
[TBL] [Abstract][Full Text] [Related]
11. Aberrant DNA methylation in melanoma: biomarker and therapeutic opportunities.
Micevic G; Theodosakis N; Bosenberg M
Clin Epigenetics; 2017; 9():34. PubMed ID: 28396701
[TBL] [Abstract][Full Text] [Related]
12. MiR-200a Regulates CDK4/6 Inhibitor Effect by Targeting CDK6 in Metastatic Melanoma.
Bustos MA; Ono S; Marzese DM; Oyama T; Iida Y; Cheung G; Nelson N; Hsu SC; Yu Q; Hoon DSB
J Invest Dermatol; 2017 Sep; 137(9):1955-1964. PubMed ID: 28526299
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation and histone acetylation regulate the expression of MGMT and chemosensitivity to temozolomide in malignant melanoma cell lines.
Chen YP; Hou XY; Yang CS; Jiang XX; Yang M; Xu XF; Feng SX; Liu YQ; Jiang G
Tumour Biol; 2016 Aug; 37(8):11209-18. PubMed ID: 26943799
[TBL] [Abstract][Full Text] [Related]
14. Aberrant p27Kip1 promoter methylation in malignant melanoma.
Worm J; Bartkova J; Kirkin AF; Straten P; Zeuthen J; Bartek J; Guldberg P
Oncogene; 2000 Oct; 19(44):5111-5. PubMed ID: 11042700
[TBL] [Abstract][Full Text] [Related]
15. Methylation in uveal melanoma.
van der Velden PA; Maat W
Br J Ophthalmol; 2009 Jan; 93(1):132. PubMed ID: 18650211
[No Abstract] [Full Text] [Related]
16. DNA methylation levels in human and murine melanoma cell lines of varying metastatic potential.
Ormerod EJ; Everett CA; Finch M; Hart IR
Cancer Res; 1986 Sep; 46(9):4342-5. PubMed ID: 2425951
[TBL] [Abstract][Full Text] [Related]
17. RASSF6 exhibits promoter hypermethylation in metastatic melanoma and inhibits invasion in melanoma cells.
Mezzanotte JJ; Hill V; Schmidt ML; Shinawi T; Tommasi S; Krex D; Schackert G; Pfeifer GP; Latif F; Clark GJ
Epigenetics; 2014 Nov; 9(11):1496-503. PubMed ID: 25482183
[TBL] [Abstract][Full Text] [Related]
18. MGMT methylation correlates with melphalan pelvic perfusion survival in stage III melanoma patients: a pilot study.
Guadagni S; Fiorentini G; Clementi M; Palumbo G; Masedu F; Deraco M; De Manzoni G; Chiominto A; Valenti M; Pellegrini C
Melanoma Res; 2017 Oct; 27(5):439-447. PubMed ID: 28486243
[TBL] [Abstract][Full Text] [Related]
19. Low frequency of p16/CDKN2A methylation in sporadic melanoma: comparative approaches for methylation analysis of primary tumors.
Gonzalgo ML; Bender CM; You EH; Glendening JM; Flores JF; Walker GJ; Hayward NK; Jones PA; Fountain JW
Cancer Res; 1997 Dec; 57(23):5336-47. PubMed ID: 9393758
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel epigenetically modified genes in human melanoma via promoter methylation gene profiling.
Liu S; Ren S; Howell P; Fodstad O; Riker AI
Pigment Cell Melanoma Res; 2008 Oct; 21(5):545-58. PubMed ID: 18627528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
